<DOC>
	<DOCNO>NCT00828867</DOCNO>
	<brief_summary>This first time human ( FTIH ) study single escalating dos investigational study drug investigate safety , tolerability , pharmacokinetics healthy subject</brief_summary>
	<brief_title>Single Dose Escalation First Time Human PK Study</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>Healthy male nonchildbearling potential female Body weight great equal 50 kg ( 110 lb ) men great equal 45 kg ( 99 lb ) woman . Body mass index ( BMI ) 18.529.9 kg/m2 inclusive . Capable give write informed consent , include compliance requirement restriction list consent form QTcB &lt; 450 msec ; QTc &lt; 480 msec subject Bundle Branch Block Screening ECG The subject positive prestudy drug/alcohol screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen . A positive test HIV antibody . History regular alcohol consumption within 6 month study define : average weekly intake great 21 unit average daily intake great 3 unit ( male ) , defined average weekly intake great 14 unit average daily intake great 2 unit ( female ) . A standard unit define 10g ethanol equivalent 100mL wine , 250mL full strength beer , 470mL light beer , 30mL spirit The subject participate clinical trial receive investigational product within following time period prior dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Pregnant female determine positive [ serum urine ] human chorionic gonadotropin ( hCG ) test screen prior dosing . Lactating female . Subjects asthma history asthma within past 6 month . History smoke history regular use tobacco nicotinecontaining product within 3 month prior screen . Consumption red wine , seville orange , grapefruit grapefruit juice , pummelo , satsuma , ugli , tangerine , tangelo , exotic citrus fruit , grapefruit hybrid fruit juices 7 day prior first dose study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>healthy subject</keyword>
	<keyword>FTIH , single dose , food effect , healthy subject , double-blind</keyword>
</DOC>